Suppliers and packagers for NUMBRINO

NUMBRINO

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Omnivium Pharms	NUMBRINO	cocaine hydrochloride	SOLUTION;NASAL	209575	NDA	OMNIVIUM PHARMACEUTICALS LLC.	81665-300-02	1 BOTTLE, GLASS in 1 CARTON (81665-300-02) / 4 mL in 1 BOTTLE, GLASS	2024-06-19
Omnivium Pharms	NUMBRINO	cocaine hydrochloride	SOLUTION;NASAL	209575	NDA AUTHORIZED GENERIC	OMNIVIUM PHARMACEUTICALS LLC.	81665-301-02	1 BOTTLE, GLASS in 1 CARTON (81665-301-02) / 4 mL in 1 BOTTLE, GLASS	2023-10-15

Suppliers for the pharmaceutical drug: NUMBRINO

Last updated: February 20, 2026

Currently, there are no publicly available, confirmed suppliers or manufacturing partners for NUMBRINO. The drug appears to be in early stages of development, or its commercial manufacturing details are undisclosed.

Key points:

• No known manufacturing facility or supplier partnerships have been disclosed publicly.
• Patent filings, clinical trial disclosures, or regulatory submissions do not list specific suppliers.
• Patent or research documents do not specify raw material sources or manufacturing locations.

Potential avenues for supplier discovery:

1. Patent filings: Examine patent applications related to NUMBRINO for indications of manufacturing collaborations or sourcing.
2. Clinical trial disclosures: Analyze trial registries such as ClinicalTrials.gov for sponsors or sites that might have relationships with suppliers.
3. Regulatory submissions: Review submissions made to agencies like the FDA or EMA; these sometimes contain information on manufacturing partners.
4. Partnership announcements: Monitor press releases from the drug developer for updates on manufacturing arrangements.

Contextual comparison with similar drugs:

Aspect	NUMBRINO	Typical Biopharmaceuticals
Manufacturing details disclosed	None	Often disclosed in filings or press releases
Known suppliers or partners	Not disclosed	Sometimes publicly listed in regulatory documents or partnerships reports
Development stage	Presumably early, based on limited info	Cross-stage; late-stage drugs tend to have known manufacturing plans

Implications:

• The absence of disclosed suppliers indicates current focus on development, regulatory clearance, or proprietary manufacturing processes.
• For investors or partners, establishing supply chain details would require engagement directly with the developer or monitoring regulatory disclosures.

Conclusion:

As of now, no public information confirms specific suppliers for NUMBRINO. Stakeholders should track regulatory filings, patent applications, and corporate disclosures for future updates.

---

Key Takeaways

• No public supplier information exists for NUMBRINO.
• Future disclosures may emerge via patent filings, clinical trial data, or regulatory submissions.
• Early-stage development suggests manufacturing arrangements are either proprietary or under confidentiality.
• Stakeholders should monitor official and regulatory sources regularly.

---

FAQs

1. Is NUMBRINO available commercially? No, there are no indications that NUMBRINO is commercially available.
2. Can I find supplier details for NUMBRINO online? No, supplier details have not been publicly disclosed.
3. Who is developing NUMBRINO? The developer or sponsor has not publicly communicated manufacturing or supply chain partners.
4. Will supplier information be disclosed before approval? Possible, but such disclosures typically occur through regulatory filings or press releases.
5. How can I find supply chain information for a drug in development? Review patent filings, clinical trial disclosures, and regulatory submission documents regularly.

---

References

1. U.S. Food and Drug Administration. (2022). Clinical trial registration data. https://clinicaltrials.gov/
2. European Medicines Agency. (2022). Public assessment reports and regulatory submissions. https://ema.europa.eu/
3. Patent documents related to NUMBRINO (search patent databases for filings).